Are you at high risk for covid?

Monoclonal antibody treatments available

Posted 10/11/21

SC health officials say they now have enough monoclonal antibodies to treat covid patients. Dr. Edward Simmer, director of the state Department of Health and Environmental Control, said the Federal …

This item is available in full to subscribers.

Subscribe to continue reading. Already a subscriber? Sign in

Get 50% of all subscriptions for a limited time. Subscribe today.

You can cancel anytime.
 

Please log in to continue

Log in

Are you at high risk for covid?

Monoclonal antibody treatments available

Posted

SC health officials say they now have enough monoclonal antibodies to treat covid patients.
Dr. Edward Simmer, director of the state Department of Health and Environmental Control, said the Federal Food and Drug Administration has authorized emergency antibody treatments.
Research shows that the treatments reduce the chance of severe disease, hospitalization and death by 70% and shorten symptom durations by an average of 4 days.
Monoclonal antibody treatments may help those in Lexington County who:
• Tested positive and had symptoms for 10 days or less
• Are at high risk of getting more serious symptoms
• Are not hospitalized or requiring supplemental oxygen
The FDA appoved 3 mAb treatments: etesevimab and bamlanivimab, REGEN-COV (casirivimab and imdevimab), and sotrovimab. 
These antibodiesdirectly block the effect of the virus in patients who are already infected.
Treatment must be ordered by a doctor or medical provider.  
The state has 11,534 ​mAb treatments available.
To date, 32,686 SC covid patients have been treated with the antibodies.

To comment, please email JerryBellune@yahoo.com

Note to iceberg watchers
More than 2,500 visitors check our site daily for dozens of news, sports, business and feature articles, obituaries and opinion pieces.
We offer them absolutely free as a community service. But you only see the tip of the iceberg.
To become a subscriber and see all of it just call us at 803-359-7633.
 

high risk, covid, monoclonal, antibody, treatment, DHEC

Comments

No comments on this item Please log in to comment by clicking here